Simplify Asset Management’s Benitec Biopharma BNTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.5M Buy
1,005,557
+443,315
+79% +$5.26M 0.19% 26
2026
Q1
$5.99M Buy
562,242
+411,079
+272% +$4.76M 0.09% 31
2025
Q4
$2.04M Buy
151,163
+72,438
+92% +$1M 0.03% 63
2025
Q3
$1.1M Buy
78,725
+9,552
+14% +$122K 0.02% 79
2025
Q2
$809K Sell
69,173
-7,562
-10% -$106K 0.04% 63
2025
Q1
$998K Buy
76,735
+398
+0.5% +$4.82K 0.04% 63
2024
Q4
$964K Sell
76,337
-40,198
-34% -$434K 0.05% 65
2024
Q3
$1.07M Buy
116,535
+65,319
+128% +$584K 0.05% 70
2024
Q2
$358K Buy
+51,216
New +$378K 0.02% 93

Other funds holding BNTC

Simplify Asset Management's BNTC Position: Q2 2026 in Review

Simplify Asset Management increased its Benitec Biopharma (BNTC) stake by 79% in Q2 2026, buying an estimated $5.26M and bringing the position to 1,005,557 shares worth $13.5M. The position accounts for 0.19% of the portfolio, ranked #26.

Simplify Asset Management first reported a position in BNTC in Q2 2024 and has held it in 9 quarters since. 4 funds tracked by Wall St. Rank hold BNTC as of Q2 2026.

  • Simplify Asset Management held 1,005,557 shares of Benitec Biopharma worth $13.5M as of Q2 2026.
  • Simplify Asset Management bought 443,315 Benitec Biopharma shares in Q2 2026, an estimated $5.26M.
  • Benitec Biopharma made up 0.19% of Simplify Asset Management's portfolio in Q2 2026, its #26 holding.
  • Simplify Asset Management first reported a position in Benitec Biopharma in Q2 2024 and has held it in 9 quarters since.
  • 4 funds tracked by Wall St. Rank held Benitec Biopharma as of Q2 2026.

Based on Simplify Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.